Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

Lead

Memorial Sloan Kettering Cancer Center

With

• Sanofi
• Roche-Genentech
• City of Hope National Medical Center
• Piedmont Hospital Research Institute
• Medical College of Wisconsin
• Queens Health Network
• Weill Medical College of Cornell University
• Memorial Cancer Institute, Florida
• University of Pittsburgh
• Long Island Jewish Medical Center
• Nebraska Cancer Specialists Methodist Estabrook Cancer Center